The risks of adverse events with mirtazapine for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis

Abstract Background Mirtazapine is used to treat depression worldwide, and the effects of mirtazapine on depression rating scales are well-known. Our primary objective was to assess the risks of adverse events with mirtazapine for major depressive disorder. Methods We searched relevant sources from...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Caroline Barkholt Kamp, Johanne Juul Petersen, Pascal Faltermeier, Sophie Juul, Christina Dam Bjerregaard Sillassen, Faiza Siddiqui, Rebecca Kjaer Andersen, Joanna Moncrieff, Mark Abie Horowitz, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-01-01
Colecção:	BMC Psychiatry
Assuntos:	Antidepressants Mirtazapine Major depressive disorder Adverse events Systematic review
Acesso em linha:	https://doi.org/10.1186/s12888-024-06396-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!